InvestorsHub Logo
icon url

Zuess421

08/27/20 10:36 AM

#111638 RE: ombowstring #111637

That is exactly what it is
icon url

justdafactss

08/27/20 10:40 AM

#111642 RE: ombowstring #111637

I wouldn't doubt WSJ getting a copy of that document to publish.

but in the WSJ article, Wursthorn wrote that CytoDyn has applied to BARDA and has been turned down
icon url

Venture_Cap

08/27/20 10:43 AM

#111645 RE: ombowstring #111637

Trust no one... only items that are true are ones that can be independently verified.

icon url

gimmeshelter

08/27/20 10:48 AM

#111647 RE: ombowstring #111637

NP also said their attys are looking into the matter. You'd think a libel suit would make these cockroach reporters scatter like citron's andrew LEFT the scene.
icon url

AaHh

08/27/20 10:49 AM

#111648 RE: ombowstring #111637

The article says “Technical experts reviewed the submission and opted not to proceed further at this time, the official added.” But in the next paragraph:

“The team responsible for reviewing the materials makes clear to companies that submissions are for informational purposes only and don't lead to funding on their own, the official added. Companies must apply to specific grant programs to receive funding, the official said, which CytoDyn hasn't done at this time.”

So it doesn’t make sense to say they were turned down if they didn’t apply for anything!
icon url

SmileyRiley_595

08/27/20 11:01 AM

#111663 RE: ombowstring #111637

I’ve already commented previously on the OWS letter so you know where I stand on that subject... as far as a retraction from the WSJ... that’s highly unlikely... With regards to the other issue regarding OWS, I am reluctant to speculate, but I believe this is a misunderstanding of semantics with Dr. Pourhassan... It was my understanding... and, I’m fairly certain a lot of discussion took place on this board regarding CytoDyn being listed on BARDA site a month or two ago... this listing would require filling out paperwork for Corona watch submission to BARDA. This step was required by any company to be considered for funding and logistical support... I don’t want to put words in Nader’s mouth but, I believe he intended to convey that CytoDyn had not applied for a grant with OWS or formally requested their support. As such, there has been nothing for BARDA to turn down... this goes back to my problem with the WSJ “Senior Administrative Official” statements... everything about those comments are inconsistent with where OWS would be in the process with CytoDyn if they were engaged in forward looking discussions IMO.
icon url

CTMedic

08/27/20 1:19 PM

#111720 RE: ombowstring #111637

Nader said in Proactive video, which I've watched four time to get it exactly:

"We have not submitted application to BARDA AND get rejected." (My emphasis added).

Mincing words, Cytodyn could absolutely be in communication with BARDA without Dr. Pourhassan's statement being false.


1. Cytodyn has applied, but has not been rejected.

2. Cytodyn has been in contact with BARDA, but communication was intiatied by BARDA, not Cytodyn.

These are at least two pathways where the statements in the Proactive video are true and the claims made that BARDA/OWS are in contact with Cytodyn are also true.

Not to get all technical and whatnot, but why not.